(Q46497036)

22 December 2017

title

Imatinib buys time for brain after stroke (English)

1 reference

22 December 2017

1 reference

Peter Rieckmann

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

22 December 2017

published in

Nature Medicine

1 reference

22 December 2017

volume

14

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

712-713

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/nm0708-712

exact match

0 references

cites work

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

Influence of the stroke code activation source on the outcome of acute ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Tissue plasminogen activator is a potent activator of PDGF-CC

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Improving outcome after stroke: overcoming the translational roadblock

1 reference

https://api.crossref.org/works/10.1038%2FNM0708-712

7 January 2021

Identifiers

DOI

10.1038/NM0708-712

1 reference

22 December 2017

1 reference

22 December 2017